Arcus Biosciences, Inc. (RCUS)
25.15
-0.25
(-0.98%)
USD |
NYSE |
Dec 11, 16:00
25.09
-0.06
(-0.24%)
After-Hours: 20:00
Arcus Biosciences Research and Development Expense (Quarterly): 141.00M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Actinium Pharmaceuticals, Inc. | 4.042M |
| Apyx Medical Corp. | 0.801M |
| Gilead Sciences, Inc. | 1.334B |
| Merck & Co., Inc. | 3.552B |
| Karyopharm Therapeutics, Inc. | 30.42M |